文献速递免疫规划传染病防控与疫情报告

马德里自治区七价和十三价肺炎球菌结合疫苗不同接种程序对肺炎球菌疾病的有效性

Effectiveness of different vaccine schedules for heptavalent and 13-valent conjugate vaccines against pneumococcal disease in the Community of Madrid.
PubMed 文献 · Vaccine · 2017-08-12

研究纳入2007至2015年马德里自治区通报的779例侵袭性肺炎球菌病病例,采用间接队列设计估计疫苗有效性。任何肺炎球菌结合疫苗至少1剂的有效性为82%(95%CI:67.8-89.9%),七价疫苗为91.9%(95%CI:76.5-97.2%),十三价疫苗为77.2%(95%CI:48.6-89.9%);完成2+1或3+1全程接种者两种疫苗有效性均为100%。

要点

  • 任何肺炎球菌结合疫苗至少1剂的有效性为82%(95%CI:67.8-89.9%)
  • 七价疫苗有效性91.9%(95%CI:76.5-97.2%),十三价疫苗77.2%(95%CI:48.6-89.9%)
  • 完成2+1或3+1全程接种者七价和十三价疫苗有效性均为100%

核心结论

  • 报告了大量儿童在有机会接种加强剂次之前发生的疫苗失败,尤其由十三价疫苗非七价疫苗血清型引起。
  • 除完成含加强剂次全程接种达到100%有效性外,七价疫苗有效性高于十三价疫苗,显示疫苗及按程序完成所有剂次的重要性。

研究设计与样本

  • 研究纳入2007至2015年报告至法定疾病监测系统的所有侵袭性肺炎球菌病病例,共779例。
  • 疫苗接种信息来自免疫登记系统,对具有血清型信息的病例采用间接队列设计估计疫苗有效性。

主要发现

  • 779例中,47.6%为初种加加强接种,20%为仅初种,15.9%为初种不完整,16.5%未接种。
  • 任何肺炎球菌结合疫苗至少1剂的有效性为82%(95%CI:67.8-89.9%)。
  • 七价疫苗有效性为91.9%(95%CI:76.5-97.2%),十三价疫苗为77.2%(95%CI:48.6-89.9%)。
  • 接受完整2+1或3+1程序的接种者中,两种疫苗有效性均为100%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The heptavalent pneumococcal conjugate vaccine (PCV-7) was added to the childhood routine vaccination program in the Community of Madrid in November of 2006 with 3+1 recommended doses and a catch-up for those under 2years old. In June 2010, PCV-7 was replaced by 13-valent vaccine (PCV-13) with 2+1 recommended doses. In July of 2012, the PCV-13 was removed from the funded program and reintroduced again (2+1 recommended doses) in December 2014. In between, children were vaccinated privately with 3+1 recommended doses of PCV-13. The aim of this study was to evaluate the effectiveness of each vaccination schedule used in the Community of Madrid. METHODS: We included all cases of invasive pneumococcal disease (IPD) reported between 2007 and 2015 to the Notifiable Diseases Surveillance System. Vaccination information was obtained from the Immunization Registry. Vaccine effectiveness (VE) was estimated using the indirect cohort design for cases with serotype information. RESULTS: A total 779 cases were included in the study. Among them 47.6% of the cases were primo-vaccinated with booster, 20% primo-vaccinated, 15.9% incompletely primo-vaccinated and 16.5% not vaccinated. The VE for ≥1 doses of any PCV was 82% (CI 95%: 67.8-89.9%): 91.9% (CI 95%: 76.5-97.2%) for PCV-7 and 77.2% (48.6-89.9%) for PCV-13. VE in those receiving the full 2+1 or 3+1 schedules was 100% for both vaccines. CONCLUSIONS: A high number of vaccine failures were reported in children before they had the opportunity to receive the booster dose, especially due to PCV-13-non-PCV-7 serotypes. VE was higher for PCV-7 compared to PCV-13, except for those that received the complete schedule with booster that achieved 100% of VE, which shows the relevance of the vaccines and complying with all doses scheduled.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Latasa P, Ordobás M, Garrido-Estepa M, et al. Effectiveness of different vaccine schedules for heptavalent and 13-valent conjugate vaccines against pneumococcal disease in the Community of Madrid. Vaccine. 2017. PMID: 28807606. doi:10.1016/j.vaccine.2017.07.089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。